2020 Apr
BRITISH JOURNAL OF HAEMATOLOGY 공동저자
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

2019 Dec
LEUKEMIA & LYMPHOMA 공동저자
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)

2019 Jan
STEM CELLS 공동저자
A Subset of Paracrine Factors as Efficient Biomarkers for Predicting Vascular Regenerative Efficacy of Mesenchymal Stromal/Stem Cells

2018 Nov
KOREAN JOURNAL OF INTERNAL MEDICINE 공동저자
The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation

2018 Mar
KOREAN JOURNAL OF INTERNAL MEDICINE 교신저자
Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia

2018 Jan
JOURNAL OF LEUKOCYTE BIOLOGY 교신저자
Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes

2017 Sep
대한혈액학회 공동저자
Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort

2016 Nov
ONCOTARGET 공동저자
Highly elevated serm lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B cell lymphoma: Results of a multicenter prospective cohort study

2016 Jun
HAEMATOLOGICA 공동저자
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: The KID study

2016 Apr
CANCER CHEMOTHERAPY AND PHARMACOLOGY 공동저자
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis

2016 Mar
ACTA HAEMATOLOGICA 공동저자
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

2016 Feb
LEUKEMIA & LYMPHOMA 공동저자
Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

2015 Sep
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation

2014 Jul
HAEMATOLOGICA 공동저자
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

2014 Jun
BLOOD RESEARCH(구 대한혈액학회지/2013년 이후 게재) 공동저자
R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma

2013 Jun
AMERICAN JOURNAL OF HEMATOLOGY 공동저자
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib

2013 May
INTERNATIONAL JOURNAL OF HEMATOLOGY 교신저자
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy

2012 Jul
INTERNATIONAL JOURNAL OF CANCER 공동저자
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy

2010 Dec
대한내과학회지(KOREAN JOURNAL OF MEDICINE) 단독
혈관신생과 세포치료

2010 Sep
BLOOD 제1저자
Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization in an ischemic hind limb mouse model